The Epstein-Barr virus (EBV), which causes mono, affects over 90% of the global population and is linked to severe health conditions like cancer and autoimmune diseases. The National Institute of Allergy and Infectious Diseases seeks healthy volunteers aged 18–29 who live in the DMV area to help test a new experimental EBV vaccine.
The study involves undergoing a physical exam, providing blood and saliva samples, and receiving three doses of the vaccine. Volunteers will attend in-person visits at the NIH and may receive compensation of up to $2,170 over the course of the trial.
For More Information
NIH Clinical Center Office of Patient Recruitment
833-JOIN-NIH
TTY users dial 7-1-1
Email: ccopr@nih.gov
Or go online
Refer to NIH study # 002288-I
Department of Health and Human Services
National Institutes of Health Clinical Center (CC)
National Institute of Allergy and Infectious Diseases (NIAID)